Activates proteins that direct calcium into bones and away from soft tissue and arteries. Works synergistically with Vitamin D3 — the two should always be taken together.
Why this form
MenaQ7® MK-7 is the most bioavailable and longest-acting form of vitamin K2, with a half-life of approximately 72 hours — enabling consistent once-daily dosing and sustained activation of bone and vascular proteins. The MenaQ7® trademark identifies the specific patented extract behind the majority of K2 clinical research.
Key benefits
Bone mineralisation (osteocalcin)
K2 activates osteocalcin, the protein that binds calcium into the bone matrix. Without sufficient K2, osteocalcin remains inactive, and calcium cannot be efficiently incorporated into bone.
Arterial calcium regulation (MGP)
K2 activates Matrix Gla Protein, which is involved in the body's normal regulation of calcium distribution — directing calcium toward bone rather than accumulating in soft tissue.
D3 synergy
Vitamin D3 upregulates calcium absorption and osteocalcin production, while K2 activates the proteins that use that calcium correctly. The two vitamins work as a pair — D3 increases the demand for K2 activation.
Supports